secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0000950170-25-058973
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health to discuss initial crofelemer POC results for MVID and SBS-IF on April 30 webcast
--------------------------------------------------------------------------------

- Data presented April 26 at ELITE PED-GI Congress by Dr. Mohamad Miqdady.
- No approved drug treatments for MVID, an ultrarare pediatric disease.
- Webcast on April 30, 2025 at 8:30 AM ET; includes KOL commentary.
- Ongoing POC IITs (3) and Phase 2 studies (2) for crofelemer in MVID and SBS-IF.
- Possible expedited regulatory pathways for crofelemer in MVID discussed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025058973/0000950170-25-058973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025058973/jagx-20250428.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-058973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer